menu search

GTBP / GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference
BRISBANE, Calif., Jan. 20, 2022 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE ® protein biologic technology platform, announced today that Dr. Greg Berk, President of R&D, Chief Medical Officer and Interim CEO will be participating in a Fireside Chat at the upcoming B. Read More
Posted: Jan 20 2022, 07:30
Author Name: PRNewsWire
Views: 110219

GTBP News  

Here's Why GT Biopharma, Inc. (GTBP) Is a Great 'Buy the Bottom' Stock Now

By Zacks Investment Research
June 2, 2023

Here's Why GT Biopharma, Inc. (GTBP) Is a Great 'Buy the Bottom' Stock Now

GT Biopharma, Inc. (GTBP) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an more_horizontal

All You Need to Know About GT Biopharma, Inc. (GTBP) Rating Upgrade to Buy

By Zacks Investment Research
May 19, 2023

All You Need to Know About GT Biopharma, Inc. (GTBP) Rating Upgrade to Buy

GT Biopharma, Inc. (GTBP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might d more_horizontal

GT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual Conference

By GlobeNewsWire
February 24, 2023

GT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual Conference

BRISBANE, CALIFORNIA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on develop more_horizontal

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference

By PRNewsWire
January 20, 2022

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference

BRISBANE, Calif., Jan. 20, 2022 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing inno more_horizontal

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference

By PRNewsWire
January 20, 2022

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference

BRISBANE, Calif., Jan. 20, 2022 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing inno more_horizontal

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference

By PRNewsWire
January 20, 2022

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference

BRISBANE, Calif., Jan. 20, 2022 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing inno more_horizontal

GT Biopharma: Shift In Therapy Strategy Reduces Attractiveness

By Seeking Alpha
November 15, 2021

GT Biopharma: Shift In Therapy Strategy Reduces Attractiveness

GT Biopharma: Shift In Therapy Strategy Reduces Attractiveness more_horizontal

GT Biopharma: Shift In Therapy Strategy Reduces Attractiveness

By Seeking Alpha
November 15, 2021

GT Biopharma: Shift In Therapy Strategy Reduces Attractiveness

GT Biopharma: Shift In Therapy Strategy Reduces Attractiveness more_horizontal


Search within

Pages Search Results: